Abbvie used AiCure’s artificial intelligence platform to visually confirm medication ingestion. This has facilitated continuous monitoring of patient treatment leading to better compliance and streamlining of clinical trials by reducing sample size.
Abbvie is a biopharmaceutical company founded in 2013.
AiCure uses visual recognition to confirm medication ingestion using smartphones, and has managed to significantly increase medication adherence among patients. This was tested in patients with Schizophrenia, measured by drug concentration levels.
90% medication adherence compared to 72% before.
Grounded in best practice. Calibrated for leadership decisions.
Powered by Best Practice AI's knowledge base — 600+ AI use cases, proprietary frameworks, and 50+ years of delivery experience. Answers are for strategic guidance, not legal or financial advice.
Free email — not hiring or booking. Optional BPAI updates for company news. Unsubscribe anytime.